Biomechanical Modeling to Improve Coronary Artery Bifurcation Stenting
Antonios P. Antoniadis(Ippokrateio General Hospital of Thessaloniki), Yiannis S. Chatzizisis(University of Miami), Deepak L. Bhatt(Mount Sinai Hospital), Peter Mortier, Shengxian Tu(Shanghai Jiao Tong University), Yoshinobu Murasato(National Hospital Organization), Johan H. C. Reiber(Erasmus University Rotterdam), George D. Giannoglou(AHEPA University Hospital), Peter Barlis(The University of Melbourne), Frank Gijsen(Erasmus MC), Gabriele Dubini(Politecnico di Milano), Jolanda J. Wentzel(Erasmus University Rotterdam), Goran Stanković(University of Belgrade), Kiyotaka Iwasaki(Waseda University), Claudio Chiastra(Politecnico di Torino), Patrick W. Serruys(Erasmus MC), Andreas A. Giannopoulos(Aristotle University of Thessaloniki), Nicolas Foin(National Heart Centre Singapore), Ghassan S. Kassab(California Medical Innovations Institute), Yves Louvard(Hôpital Privé Jacques Cartier), Elazer R. Edelman(Brigham and Women's Hospital), Yutaka Hikichi(Saga University), Francesco Migliavacca(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 102
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k